Clinical implementation of cancer genomic medicine using gene profiling test under national health insurance in Japan

被引:0
|
作者
Fukada, Ippei [1 ,2 ]
Hayashi, Naomi [1 ,3 ]
Yamazaki, Masumi [1 ,4 ]
Oh, Gyohi [1 ,3 ]
Hosonaga, Mari [2 ]
Nakajima, Takeshi [5 ]
Mori, Seiichi [6 ]
Takeuchi, Kengo [7 ]
Takahashi, Shunji [1 ,3 ,4 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Genom Med, Tokyo, Japan
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Med Oncol, Tokyo, Japan
[3] Japanese Fdn Canc Res, Canc Inst Hosp, Med Oncol, Tokyo, Japan
[4] Japanese Fdn Canc Res, Canc Inst Hosp, Ctr Adv Med Dev, Tokyo, Japan
[5] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Genet, Tokyo, Japan
[6] Japanese Fdn Canc Res, Canc Inst, Div Canc Genom, Tokyo, Japan
[7] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Pathol Ctr, Tokyo, Japan
关键词
D O I
10.1016/j.annonc.2021.05.582
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MO9-5
引用
收藏
页码:S301 / S301
页数:1
相关论文
共 50 条
  • [1] Patient survey on cancer genomic medicine in Japan under the national health insurance system
    Kage, Hidenori
    Akiyama, Nana
    Chang, Hyangri
    Shinozaki-Ushiku, Aya
    Ka, Mirei
    Kawata, Junichi
    Muto, Manabu
    Okuma, Yusuke
    Okita, Natsuko
    Tsuchihara, Katsuya
    Kikuchi, Junko
    Shirota, Hidekazu
    Hayashi, Hideyuki
    Kokuryo, Toshio
    Yachida, Shinichi
    Hirasawa, Akira
    Kubo, Makoto
    Kenmotsu, Hirotsugu
    Tanabe, Masahiko
    Ushiku, Tetsuo
    Muto, Kaori
    Seto, Yasuyuki
    Oda, Katsutoshi
    CANCER SCIENCE, 2024, 115 (03) : 954 - 962
  • [2] Trends in the needs and clinical utility of comprehensive genomic profiling test in rare cancers before and after the National Health Insurance coverage in Japan
    Sanomachi, Tomomi
    Okuma, Hitomi Sumiyoshi
    Mizuno, Takaaki
    Kojima, Yuki
    Maejima, Aiko
    Narita, Yoshitaka
    Ohe, Yuichiro
    Yamazaki, Naoya
    Kawai, Akira
    Okusaka, Takuji
    Kato, Ken
    Sunami, Kuniko
    Koyama, Takafumi
    Kohno, Takashi
    Ichikawa, Hitoshi
    Kakishima, Hiroki
    Yamamoto, Noboru
    Yatabe, Yasushi
    Yonemori, Kan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Genomic medicine in clinical practice: national genomic medicine program in Japan
    Yayoi Ando
    Tatsunori Shimoi
    Tatsuya Suzuki
    Hideki Ueno
    Natsuko Okita
    Kenichi Nakamura
    Cancer Biology & Medicine, 2024, 21 (01) : 4 - 9
  • [4] Genomic medicine in clinical practice: national genomic medicine program in Japan
    Ando, Yayoi
    Shimoi, Tatsunori
    Suzuki, Tatsuya
    Ueno, Hideki
    Okita, Natsuko
    Nakamura, Kenichi
    CANCER BIOLOGY & MEDICINE, 2024, 21 (01) : 4 - 9
  • [5] Establishment and implementation of Cancer Genomic Medicine in Japan
    Mukai, Yosuke
    Ueno, Hideki
    CANCER SCIENCE, 2021, 112 (03) : 970 - 977
  • [6] National Platform for Cancer Genomic Medicine in Japan
    Mano, Hiroyuki
    CANCER SCIENCE, 2023, 114 : 715 - 715
  • [8] The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan
    Teruhiko Yoshida
    Yasushi Yatabe
    Ken Kato
    Genichiro Ishii
    Akinobu Hamada
    Hiroyuki Mano
    Kuniko Sunami
    Noboru Yamamoto
    Takashi Kohno
    Cancer Biology & Medicine, 2024, 21 (01) : 29 - 44
  • [9] The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan
    Yoshida, Teruhiko
    Yatabe, Yasushi
    Kato, Ken
    Ishii, Genichiro
    Hamada, Akinobu
    Mano, Hiroyuki
    Sunami, Kuniko
    Yamamoto, Noboru
    Kohno, Takashi
    CANCER BIOLOGY & MEDICINE, 2024, 21 (01) : 29 - 44
  • [10] Analysis of the real-world accessibility of cancer genomic profiling after approval of national health insurance
    Suga, Junko
    Kanai, Masashi
    Mukai, Kumi
    Ashida, Kanami
    Satou, Momoko
    Matsumoto, Shigemi
    Muto, Manabu
    ANNALS OF ONCOLOGY, 2021, 32 : S326 - S326